Results 101 to 110 of about 18,473 (221)
Abstract Since the groundbreaking work of Alois Alzheimer in the early 1900s, Alzheimer's disease research has evolved immensely, most notably with the establishment of the Alzheimer's Disease Research Centers (ADRC). Fueled by the vision and funding of the National Institute on Aging (NIA), ADRCs have created a legacy through their work standardizing ...
John H. Growdon +4 more
wiley +1 more source
Abstract INTRODUCTION We compared the association between mild behavioral impairment (MBI) and first‐ versus second‐generation tau‐positron emission tomography (PET) tracers in preclinical and prodromal Alzheimer's disease (AD). METHODS We assessed 110 individuals with head‐to‐head [18F]MK6240 and [18F]Flortaucipir tau‐PET.
Isabella Bizzi +83 more
wiley +1 more source
Pathophysiology of tauopathies and modeling in non-human primate
Mon travail de thèse s’est porté principalement sur l’étude des tauopathies. Les tauopathies sont un groupe de maladies neurodégénératives caractérisées par l’accumulation et l’agrégation de la protéine pathologique tau mal-repliée.
Darricau, Morgane
core
Distribution of Big Tau Isoforms in the Human Central and Peripheral Nervous System
Objective Tau is widely studied in neurodegeneration, yet most work has focused on canonical brain tau isoforms. A longer isoform, “big tau,” produced by inclusion of exon 4a, is expressed in the peripheral nervous system (PNS) and central nervous system (CNS) regions.
Rama Krishna Koppisetti +17 more
wiley +1 more source
Targeting Microglial Transcriptional Reprogramming as a Therapy Strategy for Alzheimer's Disease
Recent human genetic studies highlight the critical role of microglial pathways in Alzheimer's disease, with risk loci enriched in microglia‐specific genes such as SPI1 and MEF2C. Dysregulation of these transcription factors contributes to disease pathogenesis.
Byungwook Kim +3 more
wiley +1 more source
(−)‐Epicatechin Rescues Memory Deficits by Activation of Autophagy in a Mouse Model of Tauopathies
In tauopathies, defects in autophagy‐lysosomal protein degradation are thought to contribute to the abnormal accumulation of aggregated tau. Recent studies have shown that (−)‐Epicatechin (Epi), a dietary flavonoid belonging to the flavan‐3‐ol subgroup ...
Yanqing Wu +12 more
doaj +1 more source
Glial contributions to neurodegeneration in tauopathies
Tauopathies are a broad set of neurodegenerative dementias characterized by aggregation of the tau protein into filamentous inclusions that can be found in neurons and glial cells.
David M. Holtzman, Cheryl E. G. Leyns
core +1 more source
The silent consequence of overdose: The case for brain injury‐informed opioid treatment
Addiction, EarlyView.
Nathaniel Day +4 more
wiley +1 more source
Ex vivo MRI was performed on AD mouse models using high‐resolution multi‐echo gradient‐echo imaging on a 9.4T scanner to generate quantitative susceptibility maps (QSM) and separate diamagnetic and paramagnetic components. Amyloid‐β$$ \beta $$ plaques were detected from the susceptibility maps.
Juan Liu +8 more
wiley +1 more source
Abstract In numerous neurodegenerative diseases known collectively as tauopathies, the microtubule‐associated protein tau forms fibrillar aggregates that are hallmarks of disease pathology. Tauopathies represent a substantial fraction of diseases associated with protein misfolding.
Mia Cervantes +5 more
wiley +1 more source

